Last updated on November 2017

ABSORB III - Randomized Controlled Trial


Brief description of study

ABSORB III - Randomized Controlled Trial

Detailed Study Description

A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects with de novo Native Coronary Artery Lesions

Clinical Study Identifier: TX81173

Contact Investigators or Research Sites near you

Start Over
Sorry. There are no research Sites conducting this study in the radius provided. ( View all Sites )